Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Oncogene|July 10, 2025
The tumor suppressor pRb and its relative p130 are required to maintain murine adult skeletal muscle homeostasisZhe Jiang, Brittany L Baechler, Huiqin Li, et al.
BMC Cancer|June 10, 2021
ERK activation via A1542/3 limonoids attenuates erythroleukemia through transcriptional stimulation of cholesterol biosynthesis genesFang Yu, Babu Gajendran, Ning Wang, et al.
International Journal of Oncology|January 3, 2020
FLI1 promotes protein translation via the transcriptional regulation of MKNK1 expressionChunlin Wang, Jialei Song, Wuling Liu, et al.
Frontiers in Immunology|March 15, 2021
FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich SyndromeChunlin Wang, Klarke M Sample, Babu Gajendran, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 25, 2021
An immunotherapeutic approach to decipher the role of long non-coding RNAs in cancer progression, resistance and epigenetic regulation of immune cellsKrishnapriya M Varier, Hemavathi Dhandapani, Wuling Liu, et al.
Molecular Medicine Reports|May 2, 2024
An intricate regulatory circuit between FLI1 and GATA1/GATA2/LDB1/ERG dictates erythroid vs. megakaryocytic differentiationChunlin Wang, Maoting Hu, Kunlin Yu, et al.
Frontiers in Pharmacology|March 27, 2025
Unraveling the molecular mechanisms of Fufangduzhong formula in alleviating high-fat diet-induced non-alcoholic fatty liver disease in miceYu Mou, Yao Tang, Xiuyan Zheng, et al.
Communications Biology|December 4, 2020
A C21-steroidal derivative suppresses T-cell lymphoma in mice by inhibiting SIRT3 via SAP18-SIN3Babu Gajendran, Krishnapriya M Varier, Wuling Liu, et al.
Frontiers in Pharmacology|August 18, 2025
L1, a 3,3'-diindolylmethane-derivative, induced ER stress-mediated apoptosis and suppressed growth through the FLI1/AKT pathway in erythroleukemia HEL cellsYi Kuang, Yong Jian, Dinghuan Wang, et al.
Molecular and Clinical Oncology|January 20, 2017
Pro-inflammatory effect of a traditional Chinese medicine formula with potent anti-cancer activity in vitro impedes tumor inhibitory potential in vivoLei Xia, Maksym Plachynta, Tangjingjun Liu, et al.
Pageof 10